Inhibition gonadotrope et endométriose. Comment lutter contre les dogmes s’ils sont erronés ?

Belaisch J, J Belaisch, J Belaïsch
Gynecologie, obstetrique & fertilite · 2009 · vol. 37(11-12) , pp. 857–862 · doi:10.1016/j.gyobfe.2009.09.011 · PMID:19819741 · W2118136005
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-14 ⓘ

This paper questions established dogma regarding the role of gonadotrope inhibition in endometriosis treatment, suggesting a re-evaluation of current therapeutic approaches.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ovarian gonadotropic inhibition is today an efficacious tool in the treatment of endometriosis mainly when associated with surgery and sometimes by itself. However, to be useful, this inhibition must be stable - without any cyclical looseness - of long duration, sometimes during years and sufficiently powerful. Depending on the severity of symptoms and that of the disease, the choice will be among GnRH agonists, gestagens and combined OCs. The recent development of continuous oral contraception with protracted amenorrhoea makes treatment by continuous hormonal administration easier for the patients with endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Gonadotropins Gonadotropins Contraceptives, Oral Contraceptives, Oral Drug Implants Endometriosis Endometriosis Endometriosis Estrogens Estrogens Female Gonadotropins Humans Mitotic Index Progestins Progestins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:13:59.677786+00:00
License: CC0 · commercial use OK